JP2021508313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508313A5 JP2021508313A5 JP2020518541A JP2020518541A JP2021508313A5 JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5 JP 2020518541 A JP2020518541 A JP 2020518541A JP 2020518541 A JP2020518541 A JP 2020518541A JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- microbial flora
- sequence variant
- tumor
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2017/075683 | 2017-10-09 | ||
| PCT/EP2017/075683 WO2018065628A2 (en) | 2016-10-07 | 2017-10-09 | Microbiota sequence variants of tumor-related antigenic epitopes |
| EP17195520.6 | 2017-10-09 | ||
| EP17195520 | 2017-10-09 | ||
| EP18305442.8 | 2018-04-11 | ||
| EP18305442 | 2018-04-11 | ||
| PCT/EP2018/077515 WO2019072871A2 (en) | 2017-10-09 | 2018-10-09 | MICROBIOTIC SEQUENCE VARIANTS OF ANTIGENIC EPITOPES ASSOCIATED WITH A TUMOR |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508313A JP2021508313A (ja) | 2021-03-04 |
| JP2021508313A5 true JP2021508313A5 (https=) | 2021-11-18 |
| JP7232825B2 JP7232825B2 (ja) | 2023-03-03 |
Family
ID=66100441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518541A Active JP7232825B2 (ja) | 2017-10-09 | 2018-10-09 | 腫瘍関連抗原エピトープの微生物叢（ｍｉｃｒｏｂｉｏｔａ）配列変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200256877A1 (https=) |
| EP (1) | EP3694541A2 (https=) |
| JP (1) | JP7232825B2 (https=) |
| KR (1) | KR102823291B1 (https=) |
| CN (1) | CN111201032B (https=) |
| AU (1) | AU2018348432B2 (https=) |
| CA (1) | CA3075363A1 (https=) |
| IL (1) | IL273648B2 (https=) |
| WO (1) | WO2019072871A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018065623A2 (en) | 2016-10-07 | 2018-04-12 | Enterome | Immunogenic compounds for cancer therapy |
| CN110022894B (zh) | 2016-10-07 | 2024-01-19 | 恩特罗姆公司 | 用于癌症疗法的免疫原性化合物 |
| WO2018065628A2 (en) | 2016-10-07 | 2018-04-12 | Enterome | Microbiota sequence variants of tumor-related antigenic epitopes |
| US20210106652A1 (en) * | 2018-04-11 | 2021-04-15 | Enterome S.A. | Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation |
| HRP20230007T1 (hr) * | 2018-04-11 | 2023-03-03 | Enterome S.A. | Antigenski peptidi, namijenjeni sprječavanju i liječenju raka |
| MX2022004598A (es) * | 2019-10-16 | 2022-09-23 | Enterome S A | Compuestos inmunogenicos para el tratamiento del cancer suprarrenal. |
| FI4021487T3 (fi) * | 2019-11-15 | 2024-02-06 | Enterome S A | Antigeenisiä peptidejä b-solun pahanlaatuisuuden ehkäisyyn ja hoitoon |
| CN112481299A (zh) * | 2020-11-20 | 2021-03-12 | 郑州大学 | 用于调节PD-1/PD-L1通路的RNAi表达质粒 |
| WO2023244997A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for inducing anticancer immunity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122017025062B8 (pt) | 2007-06-18 | 2021-07-27 | Merck Sharp & Dohme | anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento |
| US8569244B2 (en) * | 2007-08-20 | 2013-10-29 | Oncotherapy Science, Inc. | FOXM1 peptide and medicinal agent comprising the same |
| ES2532896T5 (es) | 2008-05-14 | 2018-03-20 | Immatics Biotechnologies Gmbh | Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan |
| EP3255060A1 (en) | 2008-12-09 | 2017-12-13 | F. Hoffmann-La Roche AG | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| PL2504364T3 (pl) | 2009-11-24 | 2017-12-29 | Medimmune Limited | Ukierunkowane środki wiążące przeciwko B7-H1 |
| WO2011140284A2 (en) * | 2010-05-04 | 2011-11-10 | Fred Hutchinson Cancer Research Center | Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses |
| CA2809362C (en) * | 2010-08-24 | 2020-03-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| EP2639299A1 (en) | 2012-03-16 | 2013-09-18 | Invectys | Universal cancer peptides derived from telomerase |
| AU2014239883B2 (en) | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
-
2018
- 2018-10-09 KR KR1020207013061A patent/KR102823291B1/ko active Active
- 2018-10-09 CA CA3075363A patent/CA3075363A1/en active Pending
- 2018-10-09 AU AU2018348432A patent/AU2018348432B2/en active Active
- 2018-10-09 CN CN201880065726.XA patent/CN111201032B/zh active Active
- 2018-10-09 EP EP18782459.4A patent/EP3694541A2/en active Pending
- 2018-10-09 WO PCT/EP2018/077515 patent/WO2019072871A2/en not_active Ceased
- 2018-10-09 IL IL273648A patent/IL273648B2/en unknown
- 2018-10-09 JP JP2020518541A patent/JP7232825B2/ja active Active
- 2018-10-09 US US16/753,657 patent/US20200256877A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508313A5 (https=) | ||
| IL273648B1 (en) | Microbiota sequence variants of tumor-related antigenic epitopes | |
| US5698396A (en) | Method for identifying auto-immunoreactive substances from a subject | |
| JP2006515749A5 (https=) | ||
| WO1986004093A1 (en) | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases | |
| JP2020500015A5 (https=) | ||
| JP2011523550A5 (https=) | ||
| JP2005504513A5 (https=) | ||
| JP2019507341A5 (https=) | ||
| US20240302377A1 (en) | Methods of identifying novel proteins and antigens in cancer cells | |
| JP2004154141A (ja) | リステリア検出のための方法および試薬 | |
| CA2110389A1 (fr) | Proteines de mycobacterium et applications | |
| CN1659280A (zh) | La1－乳杆菌属菌株的基因组 | |
| JP2024023268A5 (https=) | ||
| EP1238102B1 (en) | Microbial polynucleotides expressed during infection of a host | |
| JP2004512529A (ja) | 細胞内エピトープの生体内同定方法 | |
| CN107759692A (zh) | 一种抗ca125的纳米抗体 | |
| McMillan et al. | Identification and assessment of new vaccine candidates for group A streptococcal infections | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| CN104844691A (zh) | Sox2蛋白肽适配子及其鉴定 | |
| JP2020505056A5 (https=) | ||
| Vera-Bravo et al. | Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines | |
| JPH09169795A (ja) | イヌ免疫グロブリンｅペプチド断片、それをコードするｄｎａ、そのｄｎａを含む組換えベクター、その組換えベクターを含む形質転換体及び抗イヌ免疫グロブリンｅ抗体の製造法 | |
| CN109669043B (zh) | 一种mhc i结合多肽基序的鉴定方法 | |
| CN120535638B (zh) | 一种抗泛赖氨酰氧化酶家族纳米抗体或抗原结合片段与应用 |